Viramune

Active Ingredient(s): Nevirapine
FDA Approved: * June 21, 1996
Pharm Company: * BOEHRINGER INGELHEIM
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Viramune Overview

Nevirapine (NVP), marketed under the trade name Viramune among others, is a medication used to treat and prevent HIV/AIDS, specifically HIV-1.[1] It is generally recommended for use with other antiretroviral medication.[1] It may be used to prevent mother to child spread during birth but is not recommended following other exposures.[1] It is taken by mouth.[1] Common side effects include rash, headache, nausea, feeling tired, and...

Read more Viramune Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Nevirapine

Recent Viramune Forums: RSS Feed

54 193

oval white scored with 54 on one side of teh score and 193 on the other side of this white oval shaped pill of 5/8ths inch length and 5/16ths width. ## 200 mg tab of Viramune This medicine is a non-nucleoside reverse transcriptase inhibitor used to treat human immunodeficiency virus infection (HIV). This medicine is not a cure for HIV. It must be used in combination with other proven anti-HIV medicines. If this medicine is taken alone to treat HIV infection, it may stop working. Contact your doctor for more information. It may also be used to treat other conditions as determined by your doctor.

Updated

Possible Dosages for this and Related Drugs:

Nevirapine
  • Suspension: 50mg/5ml
  • Tablet: 200mg
  • Tablet, Extended Release: 100mg, 400mg
  • Tablet, For Suspension: 100mg, 50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Viramune: (8 results)

Sorted by National Drug Code
  • 0597-0046 Viramune 200 mg Oral Tablet by Boehringer Ingelheim Pharmaceuticals Inc.
  • 0597-0047 Viramune 50 mg/5ml Oral Suspension by Boehringer Ingelheim Pharmaceuticals Inc.
  • 0597-0123 24 Hr Viramune 400 mg Extended Release Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.
  • 0597-0129 24 Hr Viramune 100 mg Extended Release Tablet by Boehringer Ingelheim Pharmaceuticals, Inc.
  • 53808-0808 Viramune 200 mg Oral Tablet by State of Florida Doh Central Pharmacy
  • 54569-4561 Viramune 200 mg Oral Tablet by A-s Medication Solutions
  • 54569-6236 Viramune 400 mg Oral Tablet, Extended Release by A-s Medication Solutions
  • 54868-6370 24 Hr Viramune 400 mg Extended Release Tablet by Physicians Total Care, Inc.

Other drugs which contain Nevirapine or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 12 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA